Filing Details

Accession Number:
0001140361-15-024197
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-12 18:29:46
Reporting Period:
2015-06-10
Filing Date:
2015-06-12
Accepted Time:
2015-06-12 18:29:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1437402 Ardelyx Inc. ARDX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1101713 Gordon Ringold C/O Ardelyx, Inc.
34175 Ardenwood Blvd, Suite 100
Fremont CA 94555
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-10 10,000 $15.19 10,000 No 4 P Indirect By IRA
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By IRA
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2015-06-11 15,000 $0.00 15,000 $14.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
15,000 2025-06-11 No 4 A Direct
Footnotes
  1. This transaction was executed in multiple trades in prices ranging from $14.915 to $15.43, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.
  2. The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program.
  3. The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date.